The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II clinical trial of low-dose interleukin-2, interferon-alpha, and low-dose tegafur uracil therapy for advanced renal cell cancer.
 
Tomoyuki Kato
No Relationships to Disclose
 
Masatsugu Iwamura
No Relationships to Disclose
 
Tetsuo Fujita
No Relationships to Disclose
 
Seiichi Saito
No Relationships to Disclose
 
Yoshinori Ohshiro
No Relationships to Disclose
 
Tomoyuki Imai
No Relationships to Disclose
 
Nozomu Kawata
No Relationships to Disclose
 
Yoshihiko Tomita
No Relationships to Disclose
 
Takehiro Sejima
No Relationships to Disclose
 
Takeshi Kishida
No Relationships to Disclose
 
Tatsuo Tochigi
No Relationships to Disclose
 
Sadafumi Kawamura
No Relationships to Disclose